Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8607195 | 0.80 | CA1 (0.32) | CA1CA2CA9HTT | |
| SCHEMBL11623300 | 0.75 | — | — | |
| SCHEMBL8939812 | 0.75 | — | — | |
| SCHEMBL23927295 | 0.72 | CA1 (0.35) | CA1CA2CA9HTT | |
| SCHEMBL891765 | 0.72 | CA1 (0.35) | CA1CA2CA9HTT | |
| SCHEMBL28928423 | 0.71 | CA1 (0.32) | CA1CA2CA9HTT | |
| SCHEMBL9453379 | 0.71 | HTT (0.31) | HTT | |
| SCHEMBL9827310 | 0.71 | HTT (0.31) | HTT | |
| SCHEMBL28463221 | 0.71 | — | — | |
| SCHEMBL28469992 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353038-B2 | Methods for preparing fluorinated vinyl ethers | BAXTER INTERNATIONAL, INC. (US) | 2016-05-31 | — | — | US | claimed |
| EP-2421814-B1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INT (US) | 2013-12-25 | — | — | EP | claimed |
| EP-2421814-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | Baxter International Inc (US) | 2012-02-29 | — | — | EP | claimed |
| WO-2010123880-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INTERNATIONAL INC. (US) | 2010-10-28 | — | — | WO | claimed |
| US-20100267995-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INTERNATIONAL INC. (US) | 2010-10-21 | — | — | US | claimed |
| US-11696898-B2 | Halogenated ether compounds and methods of inducing anesthesia | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-11 | — | — | US | disclosed |
| US-9353038-B2 | Methods for preparing fluorinated vinyl ethers | BAXTER INTERNATIONAL, INC. (US) | 2016-05-31 | — | — | US | disclosed |
| EP-2421814-B1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INT (US) | 2013-12-25 | — | — | EP | disclosed |
| EP-2421814-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | Baxter International Inc (US) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010123880-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INTERNATIONAL INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100267995-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | BAXTER INTERNATIONAL INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-6551468-B1 | No pressure is produced because hydrogen chloride dissolves in the aqueous layer | O'DONNELL WILLIAM J (US) | 2003-04-22 | — | — | US | disclosed |
| EP-0706506-B1 | FLUORINATED BIS-ETHERS AND PROCESS FOR PREPARING THEM AND FLUORINATED METHYL ETHERS | DU PONT (US) | 1998-08-26 | — | — | EP | disclosed |
| EP-0706506-A1 | FLUORINATED BIS-ETHERS AND PROCESS FOR PREPARING THEM AND FLUORINATED METHYL ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0613876-B1 | Preparation of isoflurane | OHMEDA PHARMA PROD (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5449837-A | Reaction of alcohol, carbon tetrafluoride and hydrogen fluoride for bis ether | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-09-12 | — | — | US | disclosed |
| US-5416244-A | Chlorination of trifluoroethyl difluoromethyl ether and then treating with UV light in isopropanol to reduce the dichloro-by product to monochlorotrifluoroethyl difluoromethyl ether | OHMEDA PHARMACEUTICAL PRODUCTS DIVISION INC. (US) | 1995-05-16 | — | — | US | disclosed |
| US-5382704-A | Fluorinated methyl ethers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
| WO-1995001320-A1 | FLUORINATED METHYL ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-12 | — | — | WO | disclosed |
| EP-0613876-A1 | Preparation of isoflurane | Ohmeda Pharmaceutical Products Division Inc. (US) | 1994-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267995-A1 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS | VAV1, CYP4F2, CYP2F1 | CA1 399/4885CA2 691/4885CA9 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.